a public good project by the
Synthesis
Company
of California

© 2026

Zunera Khan | doi.page

0 works0 citations0 h-index

Zunera Khan

King's College London(GB)South London and Maudsley NHS Foundation Trust(GB)Columbia University(US)Macquarie University(AU)

Publications by Year

Research Areas

Dementia and Cognitive Impairment Research, Geriatric Care and Nursing Homes, COVID-19 and Mental Health, Health disparities and outcomes, Long-Term Effects of COVID-19

Most-Cited Works

→ Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults(2019)212 cited
→ Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and 2020(2020)209 cited
→ Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study(2018)187 cited
→ Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program(2015)140 cited
→ Epidemiology of Pain in People With Dementia Living in Care Homes: Longitudinal Course, Prevalence, and Treatment Implications(2017)102 cited

→ The role of the basal ganglia and its cortical connections in sequence learning: Evidence from implicit and explicit sequence learning in Parkinson's disease(2009)

97 cited

→ The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China(2023)85 cited

→ Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial(2016)65 cited

→ Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data(2023)60 cited

→ A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)(2014)32 cited